Patty Fritz is Vice President and Head of U.S. Corporate Affairs & Sustainability at UCB, where she leads a broad enterprise portfolio spanning public policy, government affairs, advocacy, communications, and sustainability; as well as the strategic priorities for UCB’s Washington, D.C. office. She also oversees UCBCares, guiding teams dedicated to delivering timely, accurate product support to patients, caregivers, healthcare professionals, and other stakeholders across UCB’s brands.

A seasoned healthcare leader with deep experience across corporate affairs, regulatory strategy, health policy, and operational leadership, Patty is known for building trusted relationships, shaping the policy and stakeholder environment, and advancing solutions that improve patient access and outcomes. She leads with a strong commitment to ensuring that the needs of people living with severe disease remain at the center of UCB’s engagement strategy, helping the company identify opportunities to create lasting value for patients, families, and the broader healthcare ecosystem.
 

Patty also leads UCB’s sustainability efforts in the United States, helping drive the company’s commitments across employee well-being, environmental stewardship, innovation, sustainable access, and ethical business practices. Her leadership reflects a belief that long-term business success and meaningful societal impact are deeply connected.

Before assuming her current role, Patty held a series of leadership positions across regulatory affairs, operational excellence, government affairs, and health policy. She led the regulatory efforts for UCB’s first U.S. product filing, Keppra® (levetiracetam), and played a pivotal role in securing FDA approvals for numerous UCB medicines. Prior to joining UCB in 1994, she held positions in government and in the pharmaceutical industry spanning regulatory affairs, clinical development, and research, bringing a uniquely broad perspective to her work at the intersection of science, policy, and patient care.

Patty has also been a champion for leadership development and inclusion, helping establish UCB’s Women in Leadership initiative. Her contributions have been widely recognized across the life sciences industry. She was named one of PharmaVOICE’s 100 most influential and inspirational leaders, received Georgia Bio’s Industry Growth Award for extraordinary contributions to the state’s life sciences sector, was recognized among the Top 50 Women Leaders of Georgia in 2023, 2024, 2025, and 2026, and was honored as a 2024 Luminary by the Healthcare Businesswomen’s Association.

Outside of UCB, Patty serves on the Board of Directors of the National Pharmaceutical Council and is a member of The Carter Center Board of Councilors. She holds a master’s degree in health care policy and administration from Mercer University, a Bachelor of Science degree in management and technology from the University of Maryland, and is a graduate of Summers 
County School of Nursing.
 

Download Bio